Missed opportunities in secondary prevention with statins
- PMID: 36332980
- DOI: 10.1136/heartjnl-2022-321855
Missed opportunities in secondary prevention with statins
Keywords: Coronary Artery Disease; Drug Monitoring; Medication Adherence; Peripheral Vascular Diseases; Quality of Health Care.
Conflict of interest statement
Competing interests: ND has received fees for giving talks or participating in advisory boards, or support for attending meetings from: Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Bouchara-Recordati, Maincare, MSD, Novartis, Sanofi, Servier, UCB and Vifor.
Comment on
-
Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017.Heart. 2023 Feb 14;109(5):388-395. doi: 10.1136/heartjnl-2022-321452. Heart. 2023. PMID: 36192149 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical